LDX Share Price Performance
AU$0
-0.03 (-100.00%)
Price AU$0
Share Pricen/a
Lumos Diagnostics Holdings Limited's (ASX:LDX) 71% Share Price Surge Not Quite Adding Up
Aug 30
Lumos Diagnostics Holdings Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
LDX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Lumos Diagnostics Holdings Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.0091
- 61.93%
- -57.93%
- 0%
About LDX
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
